Marketview360 Logo
ScreensWatchlistMarketsNewsAI AssistantPricing
⌘K
Marketview360 Logo

The fastest way to screen, analyze, and track US equities. Real-time data, powerful ratios, and clean design for the modern investor.

Product

  • Stock Screener
  • Market Overview
  • Market News
  • AI Assistance

Support

  • Help Center
  • Feedback
  • About
  • Blog
  • System Status

© 2026 Marketview360 Inc. All rights reserved.

PrivacyTermsCookiesDisclaimer
Home/
Screener/
NBTX.US
Nanobiotix logo

Nanobiotix

NBTX.US
NASDAQ•Healthcare
Low: $2.95High: $31.62
$29.95
52 Week Range
-4.37%
Market Close
Key Metrics
Peer Comparison
TickerNamePriceMkt CapP/E1D %
ABBV.USAbbVie Inc$410.36B97.92-0.81%
GILD.USGilead Sciences Inc$184.91B21.97-1.92%
BSX.USBoston Scientific Corp$114.04B39.61-1.43%
EXAS.USEXACT Sciences Corporation$19.73B0.00-0.68%
WST.USWest Pharmaceutical Services Inc$18.32B37.46-1.92%
BPMC.USBlueprint Medicines Corp$8.37B0.000.14%
MOH.USMolina Healthcare Inc$7.93B17.273.24%
MMED.USMiniMed Group, Inc. Common Stock$4.48B0.00-5.24%
AMRX.USAmneal Pharmaceuticals, Inc. Class A Common Stock$4.34B1381.00-1.74%
BCRX.USBioCryst Pharmaceuticals Inc$1.87B0.00-2.41%
Latest News

No recent news available for NBTX.US

See news for other symbols →
Company Profile

Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crysta…

Sector
Healthcare
Industry
Biotechnology
Employees
103
Founded
2020
Country
Not available
Website
https://www.nanobiotix.com
Analyst Ratings
Strong Buy
Target: $27.58(-7.9%)
Based on 4 analysts
0
Strong Sell
0
Sell
1
Hold
0
Buy
3
Strong Buy